Shield Therapeutics
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Sihleggstrasse 23, Wollerau, Schwyz, 883...Phone Number
+41 435080781Website
www.shieldtherapeutics.comRevenue
$16.6 MillionStock Symbol
STX.LIndustry
About Shield Therapeutics
Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru® is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27th July 2019.Explore more
Shield Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Shield Therapeutics Tech Stack
A closer look at the technologies used by Shield Therapeutics
See more technologies
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Shield Therapeutics
Sign Up For FreeTo access detailed company insights
Shield is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Fe... Read More
